Abstract | BACKGROUND: Quantitative flow ratio (QFR) is a novel angiography-based approach enabling fast computation of fractional flow reserve without use of pressure wire or adenosine. The objective of this investigator-initiated, multicenter, patient- and clinical assessor-blinded randomized trial is to evaluate the efficacy and cost-effectiveness of a QFR-augmented angiography-guided (QFR-guided) strategy versus an angiography-only guided (angiography-guided) strategy for percutaneous coronary intervention (PCI) in patients with coronary artery disease. METHODS: Approximately 3,830 patients will be randomized in a 1:1 ratio to a QFR-guided or an angiography-guided strategy. Included subjects scheduled for coronary angiography have at least 1 lesion eligible for PCI with 50%-90% stenosis in an artery with ≥2.5 mm reference diameter. Subjects assigned to the QFR-guided strategy will have QFR measured in each interrogated vessel and undergo PCI when QFR ≤0.80, with deferral for lesions with QFR >0.80. Those assigned to the angiography-guided strategy will undergo PCI based on angiography. Optimal medical therapy will be administered to all treated and deferred patients. The primary end point is the 1-year rate of major adverse cardiac events ( MACE), a composite of all-cause mortality, any myocardial infarction, or any ischemia-driven revascularization. The major secondary end point is 1-year MACE excluding periprocedural myocardial infarction. Other secondary end points include the individual components of MACE and cost-effectiveness end points. The sample size affords 85% power to demonstrate superiority of QFR guidance compared with angiography guidance. CONCLUSIONS: The FAVOR III China study will be the first randomized trial to examine the effectiveness and cost-effectiveness of a QFR-guided versus an angiography-guided PCI strategy in coronary artery disease patients.
|
Authors | Lei Song, Shengxian Tu, Zhongwei Sun, Yang Wang, Daixin Ding, Changdong Guan, Lihua Xie, Javier Escaned, William F Fearon, Ajay J Kirtane, Patrick W Serruys, William Wijns, Stephan Windecker, Martin B Leon, Gregg W Stone, Shubin Qiao, Bo Xu, FAVOR III China Investigators |
Journal | American heart journal
(Am Heart J)
Vol. 223
Pg. 72-80
(05 2020)
ISSN: 1097-6744 [Electronic] United States |
PMID | 32179258
(Publication Type: Clinical Trial Protocol, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2020 Elsevier Inc. All rights reserved. |
Topics |
- Coronary Angiography
- Coronary Artery Disease
(diagnostic imaging, physiopathology, surgery)
- Double-Blind Method
- Fractional Flow Reserve, Myocardial
- Humans
- Multicenter Studies as Topic
(methods)
- Percutaneous Coronary Intervention
(methods)
- Prospective Studies
- Randomized Controlled Trials as Topic
(methods)
- Surgery, Computer-Assisted
|